(Q55091443)

19 June 2018

reason for preferred rank

title

Anti‐tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts (English)

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.1997.TB00350.X

7 December 2024

Anti-tumor efficacy of paclitaxel against human lung cancer xenografts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

7 December 2024

1 reference

1 reference

1 reference

T. Yamori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

7 December 2024

S. Sato

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

7 December 2024

H. Chikazawa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

7 December 2024

T. Kadota

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

7 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9473739

7 December 2024

publication date

1 December 1997

1 reference

19 June 2018

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9473739

7 December 2024

number of pages

6

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/pmc5921337?pdf=render

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

https://europepmc.org/articles/PMC5921337

7 December 2024

file format

HyperText Markup Language

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

https://europepmc.org/articles/PMC5921337?pdf=render

7 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473739

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.1997.tb00350.x

7 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1349-7006.1997.TB00350.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.1997.tb00350.x

7 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1349-7006.1997.TB00350.X

Japanese Journal of Cancer Research

7 December 2024

published in

1 reference

19 June 2018

volume

88

1 reference

19 June 2018

issue

12

1 reference

19 June 2018

page(s)

1205-1210

1 reference

19 June 2018

An information-intensive approach to the molecular pharmacology of cancer.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Promising new agents in the treatment of non-small cell lung cancer

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Taxol stabilizes microtubules in mouse fibroblast cells

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Therapeutic response to taxol of six human tumors xenografted into nude mice

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

New colorimetric cytotoxicity assay for anticancer-drug screening

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Taxol: a review of its preclinical in vivo antitumor activity

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Promotion of microtubule assembly in vitro by taxol

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921337

[A human cell line panel for screening anti-cancer drugs]

13 August 2018

1 reference

12 December 2020

[Schedule dependency of i.v.-paclitaxel against SC-M 109 mouse lung cancer]

1 reference

12 December 2020

Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents

1 reference

12 December 2020

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

12 December 2020

Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

1 reference

19 June 2018

PMC publication ID

5921337

1 reference

19 June 2018

1 reference

19 June 2018